Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Brønsted Acidic Ionic Liquid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103360339A details a water-based ionic liquid method for synthesizing aminothiazole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN116589417B reveals ionic liquid catalysis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable green chemistry.
Patent CN116332943A reveals a recyclable ionic liquid catalytic route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN116332943A introduces a recyclable Brønsted acidic ionic liquid catalyst for synthesizing drug intermediates, offering high purity and reduced environmental impact for cost-effective manufacturing.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.